Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

肿瘤相关巨噬细胞在肝细胞癌侵袭边缘触发MAIT细胞功能障碍

阅读:1
作者:Benjamin Ruf ,Matthias Bruhns ,Sepideh Babaei ,Noemi Kedei ,Lichun Ma ,Mahler Revsine ,Mohamed-Reda Benmebarek ,Chi Ma ,Bernd Heinrich ,Varun Subramanyam ,Jonathan Qi ,Simon Wabitsch ,Benjamin L Green ,Kylynda C Bauer ,Yuta Myojin ,Layla T Greten ,Justin D McCallen ,Patrick Huang ,Rajiv Trehan ,Xin Wang ,Amran Nur ,Dana Qiang Murphy Soika ,Marie Pouzolles ,Christine N Evans ,Raj Chari ,David E Kleiner ,William Telford ,Kimia Dadkhah ,Allison Ruchinskas ,Merrill K Stovroff ,Jiman Kang ,Kesha Oza ,Mathuros Ruchirawat ,Alexander Kroemer ,Xin Wei Wang ,Manfred Claassen ,Firouzeh Korangy ,Tim F Greten

Abstract

Mucosal-associated invariant T (MAIT) cells represent an abundant innate-like T cell subtype in the human liver. MAIT cells are assigned crucial roles in regulating immunity and inflammation, yet their role in liver cancer remains elusive. Here, we present a MAIT cell-centered profiling of hepatocellular carcinoma (HCC) using scRNA-seq, flow cytometry, and co-detection by indexing (CODEX) imaging of paired patient samples. These analyses highlight the heterogeneity and dysfunctionality of MAIT cells in HCC and their defective capacity to infiltrate liver tumors. Machine-learning tools were used to dissect the spatial cellular interaction network within the MAIT cell neighborhood. Co-localization in the adjacent liver and interaction between niche-occupying CSF1R+PD-L1+ tumor-associated macrophages (TAMs) and MAIT cells was identified as a key regulatory element of MAIT cell dysfunction. Perturbation of this cell-cell interaction in ex vivo co-culture studies using patient samples and murine models reinvigorated MAIT cell cytotoxicity. These studies suggest that aPD-1/aPD-L1 therapies target MAIT cells in HCC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。